European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Pe

scientific article published on 01 September 2005

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Pe is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1085-9489.2005.10302.X
P698PubMed publication ID16221283

P2093author name stringJoint Task Force of the EFNS and the PNS
P433issue3
P921main subjectchronic inflammatory demyelinating polyradiculoneuropathyQ1088030
P304page(s)220-228
P577publication date2005-09-01
P1433published inJournal of the Peripheral Nervous SystemQ15764031
P1476titleEuropean Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society
P478volume10

Reverse relations

cites work (P2860)
Q35835712Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy
Q53299279Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient.
Q35714185Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design
Q84067083Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Q84198854Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome
Q37714082Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition
Q38334722Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy
Q24201662Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy
Q24246094Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy
Q59810481Depression with Chronic Inflammatory Demyelinating Polyneuropathy
Q46932531Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.
Q41952967Diagnostic approach to peripheral neuropathy
Q57300562Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies
Q81090374Evidence for long-term IVIg treatment of chronic inflammatory demyelinating polyradiculoneuropathy
Q22252522Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification
Q30808761Hemiplegic peripheral neuropathy accompanied with multiple cranial nerve palsy
Q24201954Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
Q24236599Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
Q36365583Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Q80454073Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Q39618476Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
Q43111229Motor-dominant chronic inflammatory demyelinating polyneuropathy.
Q38975217Neuro-ophthalmological Complications of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Q37507924Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy
Q64942852Pyrexia-associated Relapse in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Q40011079Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study
Q26864907Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies
Q46015849The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Q24246371Treatment for IgG and IgA paraproteinaemic neuropathy
Q83137774Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol
Q84475530[Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010]
Q79411766[Changes in the assessment of peripheral neuropathy in the last decade]
Q83179107[The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies]
Q83154735[Treating immune-mediated diseases]

Search more.